戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ed apoptosis induced by 15d-PGJ2, but not by ciglitazone.
2 vent B cell apoptosis induced by 15d-PGJ2 or ciglitazone.
3 lization by 15-deoxy-Delta(12,14)-PGJ(2) and ciglitazone.
4 porter gene response even in the presence of ciglitazone.
5 atment with 15-deoxy-Delta(12, 14)-PGJ(2) or ciglitazone.
6 5-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)) and ciglitazone.
7  by the PPARgamma agonists, troglitazone and ciglitazone.
8 4 mRNA is only expressed in cells exposed to ciglitazone.
9 one (2), as had been previously reported for ciglitazone (1).
10  and every hour thereafter, animals received ciglitazone (10 mg/kg) or vehicle intraperitoneally.
11 tor ligands and, similar to TPHP, found that ciglitazone (a peroxisome proliferator-activated recepto
12 lls, PPAR-gamma activation by 15d-PGJ(2) and ciglitazone (a synthetic ligand) leads to reduction in b
13 ed to dexamethasone and the PPARgamma ligand ciglitazone (a thiazolidinedione) resulted in expression
14                    Both sulindac sulfide and ciglitazone, a defined peroxisome proliferator-activated
15                                              Ciglitazone, a peroxisome proliferator-activated recepto
16 eatment of cultured human keratinocytes with ciglitazone, a PPAR-gamma activator, increases involucri
17                                              Ciglitazone, a PPAR-gamma agonist with anti-inflammatory
18                                              Ciglitazone, a PPARgamma ligand, consistently decreased
19 in vitro and in vivo antimelanoma effects of ciglitazone, a synthetic ligand-activating PPARgamma.
20  characterize the novel relationship between ciglitazone, a thiazolidinedione class of PPARgamma liga
21 l burdens were significantly lower following ciglitazone administration, which could be explained, in
22                                Unexpectedly, ciglitazone also accelerated brain abscess encapsulation
23                                              Ciglitazone also suppressed HIV-1 mRNA levels as measure
24 within the target loci prior to epiboly, and ciglitazone altered TDCIPP-induced effects on the abunda
25                                              Ciglitazone ameliorates the inflammatory response and ma
26  troglitazone, two other thiazolidinediones, ciglitazone and englitazone, exhibited similar inhibitor
27 bone marrow B cells with PPARgamma agonists (ciglitazone and GW347845X) resulted in rapid apoptosis.
28              The thiazolidinedione moiety of ciglitazone and its analogues can be replaced by an alph
29  The induction of RAR beta expression by the ciglitazone and SR11237 combination was diminished by a
30                Our results demonstrated that ciglitazone and SR11237 cooperatively inhibited the grow
31 ll-trans-retinoic acid or the combination of ciglitazone and SR11237 was able to induce RAR beta in a
32 ncreased expression of PPARgamma, as well as ciglitazone and sulindac sulfide induced expression of E
33  RXRalpha agonist plus the PPARgamma agonist ciglitazone and the inhibition of 9-cis-RA-induced coact
34 xamined the effects of the PPAR gamma ligand ciglitazone and the RXR ligand SR11237 on growth and ind
35                          In this study, both ciglitazone and troglitazone increased Src activation.
36 hat various PPARalpha (nafenopin) and gamma (ciglitazone and troglitazone) agonists rapidly induced e
37 4-PGJ2 (15d-PGJ2) and synthetic ligands like ciglitazone and troglitazone, all induce apoptosis in no
38      Our laboratory has shown that two TZDs, ciglitazone and troglitazone, rapidly induce calcium-dep
39 ha (WY14643), PPARdelta (GW1514), PPARgamma (ciglitazone), and LXR (22(R)-cholesterol or TO901317) or
40           The combination of low-dose MK886, ciglitazone, and 13-cis-retinoic acid interacted at leas
41 bited ABCA1 expression (while rosiglitazone, ciglitazone, and pioglitazone had little effect) and cho
42 Rgamma agonists 15-deoxy-prostaglandin-J(2), ciglitazone, and pioglitazone reduced intimal expansion,
43 PAR-gamma (including the TZDs rosiglitazone, ciglitazone, and pioglitazone, as well as the cyclopenta
44 s that the apoptotic effect of troglitazone, ciglitazone, and their PPARgamma-inactive analogues 5-[4
45 r kappaB protein kinase activity afforded by ciglitazone appeared to be a consequence of a physical i
46 activated receptor gamma (PPARgamma) agonist ciglitazone at high doses was able to mediate PPARgamma-
47                                 In addition, ciglitazone attenuated the expression of select inflamma
48                                              Ciglitazone, but not 15d-PGJ(2), strongly induced RAR be
49     In reporter gene assays, RXR ligands and ciglitazone, but not the PPAR gamma ligand 15d-PGJ(2), c
50 ARgamma-inactive analogs of troglitazone and ciglitazone [Delta2TG (5-[4-(6-hydroxy-2,5,7,8-tetrameth
51  the specific PPARgamma agonists LY17883 and ciglitazone, demonstrate that the PPRE element confers p
52 oliferator-activated receptor gamma-inactive ciglitazone derivative, exhibits 1- and 3-order of magni
53 t of human monocyte-derived macrophages with ciglitazone did not regulate expression of apoE.
54 port here that troglitazone and another TZD, ciglitazone, dramatically inhibited mitogen-induced cell
55 d be explained, in part, by the finding that ciglitazone enhanced S. aureus phagocytosis by microglia
56 PARgamma) agonists, such as troglitazone and ciglitazone, exhibit antitumor effects; however, the und
57 liferator-activated receptor-gamma activator ciglitazone had only a moderate effect.
58  effect on other cells of the immune system, ciglitazone has an enhancing effect on both iTregs and n
59 irst, the novel function of troglitazone and ciglitazone in targeting energy restriction provides a m
60 Treatment of cultured 3T3-L1 adipocytes with ciglitazone increased apoE mRNA levels by 2-4-fold in a
61 )-PGJ(2) and the synthetic PPARgamma agonist ciglitazone induced activation of caspase 3 and caspase
62 apacitative calcium entry by 2-APB prevented ciglitazone-induced EGFR transactivation and Erk activat
63 ation; here, Src activation by both TZDs and ciglitazone-induced EGFR transactivation were prevented
64 12,14)-prostaglandin J(2), troglitazone, and ciglitazone inhibited 17beta-estradiol-stimulated cell p
65                        The PPARgamma agonist ciglitazone inhibited HIV-1 replication in a dose-depend
66 PPARgamma agonists such as rosiglitazone and ciglitazone, is coactivated by 9 cis-retinoic acid and i
67 mation and accelerate abscess encapsulation, ciglitazone may effectively sequester brain abscesses an
68 PAR gamma, 15d-PGJ2 and a thiazolidinedione, ciglitazone, mediate significant inhibition of prolifera
69                             Moreover, E2 and ciglitazone mitigated TDCIPP-induced effects on CpG hypo
70               We investigated the effects of ciglitazone on lung inflammation after severe hemorrhage
71 totic mechanism, the effects of 15d-PGJ2 and ciglitazone on reactive oxygen species were investigated
72 tor-activated receptor (PPAR) gamma agonists ciglitazone or 15-deoxy-Delta 12,14-prostaglandin J2 res
73                       In vivo treatment with ciglitazone or 15d-PGJ(2) ameliorated hypotension and su
74                  Furthermore, treatment with ciglitazone or 15d-PGJ(2) up-regulated the expression of
75 l cells with the PPAR gamma-specific agonist ciglitazone or azPC augmented cyclooxygenase-2 expressio
76 ver, topical treatment of hairless mice with ciglitazone or troglitazone increases loricrin, involucr
77                            15d-PGJ2, but not ciglitazone, potently induced reactive oxygen species in
78 ons from intracellular stores; however, only ciglitazone produced a secondary calcium influx in the p
79                                              Ciglitazone rapidly activates extracellular signal-regul
80                        In addition, cyPG and ciglitazone reduced HIV replication in latently infected
81              In addition, 15d-PGJ(2) but not ciglitazone reduces expression of CD69 in human NK cells
82 ost disease, the immunotherapeutic effect of ciglitazone requires the presence of nTregs that express
83                                    In vitro, ciglitazone significantly enhances generation of iTregs
84                               Treatment with ciglitazone significantly reduced inhibitor kappaB prote
85 eatment with 9-hydroxyoctadecanoic acids and ciglitazone significantly rescued lal-/- pulmonary infla
86 lective thiazolidinedione PPARgamma agonist, ciglitazone, significantly reduced neuronal death in res
87 staglandin J2 (15d-PGJ2) or troglitazone and ciglitazone suppressed TGF-beta1-mediated alpha-smooth m
88 d Delta2CG, a PPARgamma-inactive analogue of ciglitazone, to conduct lead optimization to develop a n
89                                              Ciglitazone treatment ameliorated mean arterial pressure
90 ctivated receptor gamma (PPARgamma) ligands (ciglitazone, troglitazone, and 15-deoxy-Delta(12,14) pro
91  This neuroprotective effect of 15d-PGJ2 and ciglitazone was linked to increased PPARgamma DNA bindin